Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Mark Berner Hansen

(Former)

View graph of relations

Expertises

Extensive surgical and medical clinical expertise for gastrointestinal, pancreatic and hepatic diseases.

Extensive academic basic, translational and clinical research expertise with focus on neuro-endocrine physiology, pathology and pharmacology. 

Extensive experience and expertise for research and drug development (R&D) following more than 10 years employement in pharmaceutical companies (AstraZeneca and now Zealand Pharma) 

Main research areas

Gastrointestinal mucosa function in colorectal neoplasia; Gastrointestinal mucosa function in inflammatory bowel disease; Acute pancreatitis; Non-Alchoholic Steato-Hepatitis (NASH); Small Bowel Syndrome (SBS).

Current research

Novel pharmacological targets for prevention and treatment of colorectal neoplasia/cancer

Novel pharmacological targets for the treatment of inflammatory bowel disease

Novel pharmacological tragerts for the treatment of NASH and SBS

Potential conflicts of interest

VP Gastroenterology R&D employee at Zealand Pharma, a Copenhagen-based biotech company, developing medicines for endocrine, gastrointestinal and pancreatic indications.  

ID: 32367508